Form D · Pharmaceuticals
IMMUCELL CORP /DE/
Portland, ME · CIK 0000811641
Offering snapshot reported Oct 24, 2016 · SEC filing
- Reported sold
- $3.46M Indefinite offering
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 21, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 24, 2016 | Initial | $3,464,370 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $208K
- Finders' fees
- $0
- Form D file number
- 021-273064
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| CRAIG-HALLUM CAPITAL GROUP LLC | 121395 |
Source: Form D, filed Oct 24, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael F Brigham | Director, Executive |
| Bobbi Brockmann | Executive |
| Joseph Crabb | Director, Executive |
| David Cunningham | Director |
| Linda Rhodes | Director |
| Jonathan Rothschild | Director |
| David Tomsche | Director |
| Paul Wainman | Director |
| Elizabeth Williams | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
56 Evergreen Drive
Portland, ME, 04103
Portland, ME, 04103